SAS and Carolina partner to accelerate antiviral drug development

Posted Nov 19, 2021
SAS, a leader in analytics and software services, and the University of North Carolina are teaming up to transform the drug development process to prevent infectious disease threats from turning into a pandemic like COVID-19. The partnership is focused on the work of the University’s Rapidly Emerging Antiviral Drug Development Initiative (READDI). (UNC.edu)

Related: Campus Connections

Audio: 100 Years of Kenan Stadium - Commencement VIPs
You never know who you’ll see at Kenan Stadium. For Chapelboro’s own Kenny Dike, his commencement in the spring of 2001 featured a few special...
Tue Sep 29, 2026

A guide to the most iconic UNC campus characters
The beloved campus crossing guards by South Road have left the most positive effect on my time at UNC out of any of the campus...
Sun Sep 27, 2026

Video: Carolina Insider - Ken Cleary On Montross Day Of Service
UNC Assistant Athletic Director for New Media Ken Cleary discusses his role in GoHeels Productions (1:14), his personal journey with cancer and recovery (12:47), and...
Fri Sep 25, 2026

Audio: 100 Years of Kenan Stadium - 'My Most Memorable Day'
Spring commencement is one of the busiest days of the year at Kenan Stadium. It’s an emotional day for UNC graduates, marking the end of...
Thu Sep 24, 2026